{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:27:55Z","timestamp":1793996875900,"version":"4.8.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Noncommunicable Chronic Disease-National Science and Technology Major Project of China","award":["2026ZD0555000"],"award-info":[{"award-number":["2026ZD0555000"]}]},{"name":"Engineering Research Center of Cardiovascular Diagnostic and Therapeutic Technologies and Devices"},{"DOI":"10.13039\/501100020930","name":"Ministry of Education","doi-asserted-by":"publisher","award":["1300-12400606"],"award-info":[{"award-number":["1300-12400606"]}],"id":[{"id":"10.13039\/501100020930","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Optimal management of oral anticoagulation (OAC) after atrial fibrillation (AF) ablation remains uncertain. We evaluated thromboembolic and bleeding outcomes associated with OAC discontinuation vs. continuation at a clinically relevant 6-month post-ablation landmark.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This target trial emulation used data from a multicentre prospective registry in China. Patients with CHA2DS2-VA scores \u22652, no prior thromboembolism, and no atrial arrhythmia recurrence within 6 months after ablation were classified according to OAC discontinuation or continuation at the 6-month landmark. The primary outcome was the composite of stroke, systemic embolism, and major bleeding. Inverse probability weighting was applied, with intention-to-treat as the primary analysis. Among 8339 patients (mean age 68 years; 40.5% women), 4406 discontinued and 3933 continued OAC. The risk of the primary outcome did not differ significantly between groups [weighted hazard ratio (HR) 0.93; 95% CI 0.67\u20131.29]. Thromboembolic risk was similarly comparable (HR 0.96; 95% CI 0.69\u20131.35). Clinically relevant non-major bleeding occurred less frequently after OAC discontinuation (HR 0.68; 95% CI 0.47\u20130.97). Findings were consistent in sensitivity analyses. Annualized thromboembolic rates after discontinuation were &amp;lt;1% in patients with CHA2DS2-VA scores 2\u20133 but 1.52% in those with scores \u22654.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among patients without prior thromboembolism who remained arrhythmia-free at 6 months after AF ablation, OAC discontinuation was not associated with a difference in the composite outcome of stroke, systemic embolism and major bleeding compared with OAC continuation. Residual risk remained low in patients with CHA2DS2-VA scores 2\u20133 but exceeded conventional thresholds in those with scores \u22654.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euag197","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:22:23Z","timestamp":1785756143000},"source":"Crossref","is-referenced-by-count":1,"title":["Residual thromboembolic risk and outcomes of oral anticoagulation discontinuation after atrial fibrillation ablation: a target trial emulation"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6264-0175","authenticated-orcid":false,"given":"Xiaodong","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2418-2389","authenticated-orcid":false,"given":"Liu","family":"He","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-6589","authenticated-orcid":false,"given":"Jue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7140-3059","authenticated-orcid":false,"given":"Qifan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1311-4299","authenticated-orcid":false,"given":"Zixu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3028-6794","authenticated-orcid":false,"given":"Zejun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2715-4806","authenticated-orcid":false,"given":"Mingxiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5946-3018","authenticated-orcid":false,"given":"Fadong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8874-6955","authenticated-orcid":false,"given":"Xiaoxia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-1802","authenticated-orcid":false,"given":"Song","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4670-0670","authenticated-orcid":false,"given":"Junmeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5695-5058","authenticated-orcid":false,"given":"Yunlong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4604-5346","authenticated-orcid":false,"given":"Deyong","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-4421","authenticated-orcid":false,"given":"Caihua","family":"Sang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-8707","authenticated-orcid":false,"given":"Xin","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzeng","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5387-5957","authenticated-orcid":false,"given":"Changsheng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029 ,","place":["China"]},{"name":"Engineering Research Center of Medical Devices for Cardiovascular Diseases, Ministry of Education , Beijing ,","place":["China"]},{"name":"National Clinical Research Center for Cardiovascular Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2026090112015805500_euag197-B1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCULATIONAHA.121.055297","article-title":"Association between age and outcomes of catheter ablation versus medical therapy for atrial fibrillation: results from the CABANA trial","volume":"145","author":"Bahnson","year":"2022","journal-title":"Circulation"},{"key":"2026090112015805500_euag197-B2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.2024.24438","article-title":"Pulmonary vein isolation with optimized linear ablation vs pulmonary vein isolation alone for persistent AF: the PROMPT-AF randomized clinical trial","volume":"333","author":"Sang","year":"2025","journal-title":"JAMA"},{"key":"2026090112015805500_euag197-B3","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.2025.14669","article-title":"Lifelong anticoagulation after AF ablation-time to reconsider?","volume":"334","author":"Gerstenfeld","year":"2025","journal-title":"JAMA"},{"key":"2026090112015805500_euag197-B4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMe2517576","article-title":"Anticoagulation after ablation for atrial fibrillation - navigating the OCEAN of possibilities","volume":"394","author":"Albert","year":"2026","journal-title":"N Engl J Med"},{"key":"2026090112015805500_euag197-B5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2026090112015805500_euag197-B6","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090112015805500_euag197-B7","doi-asserted-by":"crossref","first-page":"euae298","DOI":"10.1093\/europace\/euae298","article-title":"Spotlight on the 2024 ESC\/EACTS management of atrial fibrillation guidelines: 10 novel key aspects","volume":"26","author":"Rienstra","year":"2024","journal-title":"Europace"},{"key":"2026090112015805500_euag197-B8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007612","article-title":"Outcomes and anticoagulation use after catheter ablation for atrial fibrillation","volume":"12","author":"Freeman","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026090112015805500_euag197-B9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/eurheartj\/ehu421","article-title":"Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark","volume":"36","author":"Karasoy","year":"2015","journal-title":"Eur Heart J"},{"key":"2026090112015805500_euag197-B10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jamacardio.2016.4179","article-title":"Assessment of use vs discontinuation of oral anticoagulation after pulmonary vein isolation in patients with atrial fibrillation","volume":"2","author":"Sj\u00e4lander","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026090112015805500_euag197-B11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/eurheartj\/ehad798","article-title":"Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks","volume":"45","author":"Kanaoka","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090112015805500_euag197-B12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jama.2025.14679","article-title":"Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial","volume":"344","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"2026090112015805500_euag197-B13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2509688","article-title":"Antithrombotic therapy after successful catheter ablation for atrial fibrillation","volume":"394","author":"Verma","year":"2025","journal-title":"N Engl J Med"},{"key":"2026090112015805500_euag197-B14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(24)00037-1","article-title":"Secondary stroke prevention in people with atrial fibrillation: treatments and trials","volume":"23","author":"Seiffge","year":"2024","journal-title":"Lancet Neurol"},{"key":"2026090112015805500_euag197-B15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12872-016-0308-1","article-title":"Rationale and design of the Chinese atrial fibrillation registry study","volume":"16","author":"Du","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"2026090112015805500_euag197-B16","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1161\/01.CIR.0000131893.41821.D1","article-title":"ACC\/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical data standards (writing committee to develop data standards on atrial fibrillation)","volume":"109","author":"McNamara","year":"2004","journal-title":"Circulation"},{"key":"2026090112015805500_euag197-B17","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.amjcard.2011.06.017","article-title":"Practice-level variation in warfarin use among outpatients with atrial fibrillation (from the NCDR PINNACLE program)","volume":"108","author":"Chan","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026090112015805500_euag197-B18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-084380","article-title":"Continued versus discontinued oral anticoagulant treatment for unprovoked venous thromboembolism: target trial emulation","volume":"391","author":"Lin","year":"2025","journal-title":"Br Med J"},{"key":"2026090112015805500_euag197-B19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jama.2025.13350","article-title":"Transparent reporting of observational studies emulating a target trial-the TARGET statement","volume":"334","author":"Cashin","year":"2025","journal-title":"JAMA"},{"key":"2026090112015805500_euag197-B20","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.hrthm.2025.10.012","article-title":"Asymptomatic atrial fibrillation: clinical characteristics, outcomes, and prognostic impact of rhythm control","volume":"23","author":"Peng","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026090112015805500_euag197-B21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/sim.8471","article-title":"A causal framework for classical statistical estimands in failure-time settings with competing events","volume":"39","author":"Young","year":"2020","journal-title":"Stat Med"},{"key":"2026090112015805500_euag197-B22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/europace\/euz235","article-title":"The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese atrial fibrillation registry study","volume":"22","author":"Yang","year":"2020","journal-title":"Europace"},{"key":"2026090112015805500_euag197-B23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/ehad200","article-title":"Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation","volume":"44","author":"Benz","year":"2023","journal-title":"Eur Heart J"},{"key":"2026090112015805500_euag197-B24","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"2026090112015805500_euag197-B25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa2513310","article-title":"Left atrial appendage closure or medical therapy in atrial fibrillation","volume":"394","author":"Landmesser","year":"2026","journal-title":"N Engl J Med"},{"key":"2026090112015805500_euag197-B26","doi-asserted-by":"crossref","first-page":"euae043","DOI":"10.1093\/europace\/euae043","article-title":"2024 European heart rhythm association\/heart rhythm society\/Asia Pacific heart rhythm society\/Latin American heart rhythm society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"2026090112015805500_euag197-B27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.hrthm.2025.05.075","article-title":"Time course of recurrent arrhythmias in clinical trials of catheter ablation for paroxysmal atrial fibrillation: a pooled analysis","volume":"23","author":"Aguilar","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026090112015805500_euag197-B28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamacardio.2021.0852","article-title":"Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials","volume":"6","author":"Turagam","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026090112015805500_euag197-B29","doi-asserted-by":"crossref","first-page":"euaf250","DOI":"10.1093\/europace\/euaf250","article-title":"Adherence to oral thromboprophylaxis in atrial fibrillation: an overview for clinicians","volume":"27","author":"Potpara","year":"2025","journal-title":"Europace"},{"key":"2026090112015805500_euag197-B30","doi-asserted-by":"crossref","first-page":"euae264","DOI":"10.1093\/europace\/euae264","article-title":"Sex- and age-specific differences in the use of antiarrhythmic therapies among atrial fibrillation patients: a nationwide cohort study","volume":"26","author":"Salmela","year":"2024","journal-title":"Europace"},{"key":"2026090112015805500_euag197-B31","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"Friberg","year":"2016","journal-title":"Eur Heart J"},{"key":"2026090112015805500_euag197-B32","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.7326\/ANNALS-25-00253","article-title":"Catheter and surgical ablation for atrial fibrillation: a systematic review and meta-analysis","volume":"178","author":"Montan\u00e9","year":"2025","journal-title":"Ann Intern Med"},{"key":"2026090112015805500_euag197-B33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"2026090112015805500_euag197-B34","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.jacc.2020.04.065","article-title":"Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial","volume":"75","author":"Poole","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026090112015805500_euag197-B35","doi-asserted-by":"crossref","first-page":"euae104","DOI":"10.1093\/europace\/euae104","article-title":"Comprehensive atrial fibrillation burden and symptom reduction post-ablation: insights from DECAAF II","volume":"26","author":"Noujaim","year":"2024","journal-title":"Europace"},{"key":"2026090112015805500_euag197-B36","article-title":"Patterns of postablation recurrence and adverse cardiovascular outcomes in patients with atrial fibrillation","volume":"14","author":"Li","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026090112015805500_euag197-B37","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/eurheartj\/ehae291","article-title":"Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilization","volume":"45","author":"Crowley","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090112015805500_euag197-B38","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/eurheartj\/ehae373","article-title":"Atrial fibrillation burden: a new outcome predictor and therapeutic target","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090112015805500_euag197-B39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamacardio.2018.1176","article-title":"Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study","volume":"3","author":"Go","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026090112015805500_euag197-B40","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation"},{"key":"2026090112015805500_euag197-B41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijcard.2008.10.004","article-title":"Influence of the duration of holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up","volume":"139","author":"Dagres","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026090112015805500_euag197-B42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2020.12.077","article-title":"Long-term intermittent versus short continuous heart rhythm monitoring for the detection of atrial fibrillation recurrences after catheter ablation","volume":"329","author":"Hermans","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026090112015805500_euag197-B43","doi-asserted-by":"crossref","first-page":"euad166","DOI":"10.1093\/europace\/euad166","article-title":"The influence of atrial high-rate episodes on stroke and cardiovascular death: an update","volume":"25","author":"Toennis","year":"2023","journal-title":"Europace"},{"key":"2026090112015805500_euag197-B44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"2026090112015805500_euag197-B45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"2026090112015805500_euag197-B46","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"2026090112015805500_euag197-B47","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jacc.2024.05.002","article-title":"Apixaban vs aspirin according to CHA(2)DS(2)-VASc score in subclinical atrial fibrillation: insights from ARTESiA","volume":"84","author":"Lopes","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026090112015805500_euag197-B48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/eurheartj\/ehaf793","article-title":"Atrial cardiomyopathy: markers and outcomes","volume":"47","author":"Vad","year":"2026","journal-title":"Eur Heart J"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euag197\/70479899\/euag197.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/8\/euag197\/70479899\/euag197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/8\/euag197\/70479899\/euag197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:02:43Z","timestamp":1788278563000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euag197\/8751066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euag197","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]},"article-number":"euag197"}}